Your browser doesn't support javascript.
loading
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Grever, Michael R; Abdel-Wahab, Omar; Andritsos, Leslie A; Banerji, Versha; Barrientos, Jacqueline; Blachly, James S; Call, Timothy G; Catovsky, Daniel; Dearden, Claire; Demeter, Judit; Else, Monica; Forconi, Francesco; Gozzetti, Alessandro; Ho, Anthony D; Johnston, James B; Jones, Jeffrey; Juliusson, Gunnar; Kraut, Eric; Kreitman, Robert J; Larratt, Loree; Lauria, Francesco; Lozanski, Gerard; Montserrat, Emili; Parikh, Sameer A; Park, Jae H; Polliack, Aaron; Quest, Graeme R; Rai, Kanti R; Ravandi, Farhad; Robak, Tadeusz; Saven, Alan; Seymour, John F; Tadmor, Tamar; Tallman, Martin S; Tam, Constantine; Tiacci, Enrico; Troussard, Xavier; Zent, Clive S; Zenz, Thorsten; Zinzani, Pier Luigi; Falini, Brunangelo.
Afiliação
  • Grever MR; Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital, Columbus, OH.
  • Abdel-Wahab O; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Andritsos LA; Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital, Columbus, OH.
  • Banerji V; Section of Hematology/Oncology, University of Manitoba, Winnipeg, MB, Canada.
  • Barrientos J; Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hofstra University, Hempstead, NY.
  • Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital, Columbus, OH.
  • Call TG; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Catovsky D; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
  • Dearden C; Department of Haemato-Oncology, Royal Marsden Biomedical Research Centre, London, United Kingdom.
  • Demeter J; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Else M; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
  • Forconi F; Haematology Department, University Hospital Trust and Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Gozzetti A; Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
  • Ho AD; Department of Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Johnston JB; Section of Hematology/Oncology, University of Manitoba, Winnipeg, MB, Canada.
  • Jones J; Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital, Columbus, OH.
  • Juliusson G; Department of Hematology, Skåne University Hospital and Stem Cell Center, Lund University, Lund, Sweden.
  • Kraut E; Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital, Columbus, OH.
  • Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Larratt L; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Lauria F; Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
  • Lozanski G; Department of Pathology, The Ohio State University, Columbus, OH.
  • Montserrat E; Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Park JH; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Polliack A; Department of Hematology, Hadassah University Hospital and Hebrew University Medical School, Jerusalem, Israel.
  • Quest GR; Department of Laboratory Medicine and Pathology, University Health Network, Toronto, ON, Canada.
  • Rai KR; Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hofstra University, Hempstead, NY.
  • Ravandi F; Section of Developmental Therapeutics, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Robak T; Department of Hematology, Medical University of Lodz, Lodz, Poland.
  • Saven A; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA.
  • Seymour JF; Haematology Department, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
  • Tadmor T; Hematology Unit, Bnai-Zion Medical Center, and the Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
  • Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Tam C; Haematology Department, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
  • Tiacci E; Institute of Hematology, Department of Medicine, University and Hospital of Perugia, Perugia, Italy.
  • Troussard X; Department of Hematology, Centre Hospitalier Universitaire Côte de Nacre, Caen, France.
  • Zent CS; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Zenz T; Department of Molecular Therapy in Hematology and Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany; and.
  • Zinzani PL; Institute of Hematology "Seràgnoli," University of Bologna, Bologna, Italy.
  • Falini B; Institute of Hematology, Department of Medicine, University and Hospital of Perugia, Perugia, Italy.
Blood ; 129(5): 553-560, 2017 02 02.
Article em En | MEDLINE | ID: mdl-27903528
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia de Células Pilosas / Pentostatina / Cladribina / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia de Células Pilosas / Pentostatina / Cladribina / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article